SURMODICS INC·4

Nov 19, 6:10 PM ET

KNIGHT SUSAN E 4

4 · SURMODICS INC · Filed Nov 19, 2025

Insider Transaction Report

Form 4
Period: 2025-11-19
Transactions
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-193,6340 total
    Exercise: $55.24Exp: 2026-02-13Common Stock (3,634 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-193,5550 total
    Exercise: $41.81Exp: 2029-02-10Common Stock (3,555 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-194,1550 total
    Exercise: $31.89Exp: 2031-02-08Common Stock (4,155 underlying)
  • Disposition to Issuer

    Common Stock

    2025-11-1937,2400 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-194,5480 total
    Exercise: $39.58Exp: 2027-02-13Common Stock (4,548 underlying)
  • Disposition to Issuer

    Employee Stock Options (right to buy)

    2025-11-193,1960 total
    Exercise: $53.86Exp: 2028-02-11Common Stock (3,196 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-195,0400 total
    Exercise: $28.98Exp: 2030-02-09Common Stock (5,040 underlying)
Footnotes (3)
  • [F1]Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs.
  • [F2]As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock.
  • [F3]Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4